<DOC>
	<DOCNO>NCT01208753</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability multiple ascend oral dos ( MAD ) GLPG0555 give healthy subject 13 day compare placebo , evaluate relative bioavailability pharmacokinetics ( PK ) two different aqueous suspension GLPG0555 administer 3 day . Finally , aim characterize PK pharmacodynamics ( PD ) GLPG0555 multiple oral administration .</brief_summary>
	<brief_title>Pharmacokinetics/Pharmacodynamics ( PK/PD ) Multiple Oral Doses GLPG0555 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>healthy male , age 1850 year BMI 1830 kg/mÂ² , inclusive . significantly abnormal platelet function coagulopathy smoke drug alcohol abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>